Vericel (VCEL) Non-Current Deffered Revenue (2016 - 2019)

Vericel (VCEL) reported Non-Current Deffered Revenue of $1.9 million for Q2 2019, little changed on a YoY basis from $1.9 million in Q2 2018, and little changed sequentially from $1.9 million in Q1 2019.

Vericel (VCEL) Non-Current Deffered Revenue (2016 - 2019) Analysis & Trends

Vericel (VCEL) has 4 years of Non-Current Deffered Revenue data on file, last reported at $1.9 million in Q2 2019.

  • For the quarter ending Q2 2019, Non-Current Deffered Revenue changed 0.0% year-over-year to $1.9 million; the trailing twelve-month figure through Jun 2019 stood at $1.9 million (changed 0.0% YoY), and the FY2018 full-year result was $1.7 million, down 19.09% from the prior year.
  • Non-Current Deffered Revenue steadied at $1.9 million in Q2 2019, from $1.9 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.1 million in Q4 2017 to a low of $820000.0 in Q2 2016.
  • A 4-year average of $1.6 million and a median of $1.7 million in 2016 frame the typical range for Non-Current Deffered Revenue.
  • Peak annual rise in Non-Current Deffered Revenue reached 111.11% in 2018, while the deepest fall reached 19.09% in 2018.
  • Tracing VCEL's Non-Current Deffered Revenue over 4 years: stood at $1.7 million in 2016, then rose by 22.05% to $2.1 million in 2017, then dropped by 19.09% to $1.7 million in 2018, then grew by 14.05% to $1.9 million in 2019.
  • Business Quant data shows VCEL's Non-Current Deffered Revenue at $1.9 million in Q2 2019, $1.9 million in Q1 2019, and $1.7 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 1.90 Mn
Mar 31, 2019 1.90 Mn
Dec 31, 2018 1.67 Mn
Sep 30, 2018 1.81 Mn
Jun 30, 2018 1.90 Mn
Mar 31, 2018 1.70 Mn
Dec 31, 2017 2.06 Mn
Sep 30, 2017 1.00 Mn
Jun 30, 2017 900,000.00
Mar 31, 2017 1.63 Mn
Dec 31, 2016 1.69 Mn
Sep 30, 2016 1.23 Mn
Jun 30, 2016 820,000.00